Literature DB >> 15065600

Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer.

Gaynor Davies1, Giles H Cunnick, Robert E Mansel, Malcolm D Mason, Wen G Jiang.   

Abstract

Tumour endothelial markers (TEMs) are a newly discovered family of endothelial markers associated with tumour specific angiogenesis. This study sought to examine the levels of expression for TEMs in human breast cancer. Breast cancer tissues (n = 120) together with normal background tissues (n = 33) were obtained after surgery. RNA was extracted from frozen sections for gene amplification. The expression of TEMs was assessed using RT-PCR and the quantity of their transcripts was determined using real-time-quantitative PCR (Q-RT-PCR). TEM-7R (P = 0.05) and TEM-8 (P < 0.01) were significantly raised in breast cancer tissues compared with the levels detected in normal background tissues. After a median follow-up of 72.2 months it was found that patients who had recurrent disease and/or who had died from breast cancer had a significantly (P < 0.05) elevated level of TEM-1 compared to those patients who were disease free. In addition, elevated levels of TEM-4, TEM-5, TEM-6, TEM-7 and TEM-7R were also raised in breast cancer tissues. Patients who had developed nodal involvement exhibited significantly (P < 0.05) high levels of TEM-1 and TEM-7R compared to patients who were node negative. Furthermore, the levels of TEMs did not correlate with tumour or histological grade. We conclude that elevated levels of TEM-1, TEM-7R and TEM-8 (but not TEM-2, 4, 5, 6 and 7) are associated with either nodal involvement, and/or disease progression, and may therefore, have a prognostic value in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065600     DOI: 10.1023/b:clin.0000017168.83616.d0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  31 in total

1.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

Review 2.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

Review 3.  The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms.

Authors:  A Colombatti; P Bonaldo
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

Review 4.  Ligand recognition by the I domain-containing integrins.

Authors:  S K Dickeson; S A Santoro
Journal:  Cell Mol Life Sci       Date:  1998-06       Impact factor: 9.261

Review 5.  The incidence of breast cancer: the global burden, public health considerations.

Authors:  J F Forbes
Journal:  Semin Oncol       Date:  1997-02       Impact factor: 4.929

6.  Cell surface tumor endothelial markers are conserved in mice and humans.

Authors:  E B Carson-Walter; D N Watkins; A Nanda; B Vogelstein; K W Kinzler; B St Croix
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

7.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

8.  The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.

Authors:  Gaynor Davies; Malcolm D Mason; Tracey A Martin; Christian Parr; Gareth Watkins; Jane Lane; Kunio Matsumoto; Toshikazu Nakamura; Wen G Jiang
Journal:  Int J Cancer       Date:  2003-09-01       Impact factor: 7.396

9.  Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.

Authors:  Yasushi Nakamura; Hironao Yasuoka; Masahiko Tsujimoto; Qifeng Yang; Shigeru Imabun; Masaaki Nakahara; Kazuyasu Nakao; Misa Nakamura; Ichiro Mori; Kennichi Kakudo
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

10.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

Authors:  D Maglione; V Guerriero; G Viglietto; P Delli-Bovi; M G Persico
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

View more
  40 in total

1.  Novel surface targets and serum biomarkers from the ovarian cancer vasculature.

Authors:  Dimitra Sasaroli; Phyllis A Gimotty; Harsh B Pathak; Rachel Hammond; Eleni Kougioumtzidou; Dionyssios Katsaros; Ron Buckanovich; Karthik Devarajan; Raphael Sandaltzopoulos; Andrew K Godwin; Nathalie Scholler; George Coukos
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

2.  Prognostic values of tumor endothelial markers in patients with colorectal cancer.

Authors:  K A Rmali; M C A Puntis; W G Jiang
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

3.  Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.

Authors:  Aizhi Zhao; Selene Nunez-Cruz; Chunsheng Li; George Coukos; Don L Siegel; Nathalie Scholler
Journal:  J Immunol Methods       Date:  2010-09-15       Impact factor: 2.303

4.  Development of 124I immuno-PET targeting tumor vascular TEM1/endosialin.

Authors:  Ann-Marie Chacko; Chunsheng Li; Madhura Nayak; John L Mikitsh; Jia Hu; Catherine Hou; Luigi Grasso; Nicholas C Nicolaides; Vladimir R Muzykantov; Chaitanya R Divgi; George Coukos
Journal:  J Nucl Med       Date:  2014-02-13       Impact factor: 10.057

5.  Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model.

Authors:  Chunsheng Li; Ann-Marie Chacko; Jia Hu; Kosei Hasegawa; Jennifer Swails; Luigi Grasso; Wafik S El-Deiry; Nicholas Nicolaides; Vladimir R Muzykantov; Chaitanya R Divgi; George Coukos
Journal:  Cancer Biol Ther       Date:  2014-02-19       Impact factor: 4.742

6.  Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration.

Authors:  Brian Tomkowicz; Katherine Rybinski; Brian Foley; Wolfgang Ebel; Brad Kline; Eric Routhier; Philip Sass; Nicholas C Nicolaides; Luigi Grasso; Yuhong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

7.  Prognostic value of tumour endothelial markers in patients with endometrial cancer.

Authors:  Nick A Bersinger; Brigitte Schneider; Stephan A Vorburger; Silke Johann; Daniel Candinas; Michael D Mueller
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

8.  Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors.

Authors:  Akash Nanda; Baktiar Karim; Zhongsheng Peng; Guosheng Liu; Weiping Qiu; Christine Gan; Bert Vogelstein; Brad St Croix; Kenneth W Kinzler; David L Huso
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

9.  Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy.

Authors:  Reza Mehran; Monique Nilsson; Mehrdad Khajavi; Zhiqiang Du; Tina Cascone; Hua Kang Wu; Andrea Cortes; Li Xu; Amado Zurita; Robert Schier; Bernhard Riedel; Randa El-Zein; John V Heymach
Journal:  Cancer Res       Date:  2014-03-13       Impact factor: 12.701

10.  Characterization of TEM1/endosialin in human and murine brain tumors.

Authors:  Eleanor B Carson-Walter; Bethany N Winans; Melissa C Whiteman; Yang Liu; Sally Jarvela; Hannu Haapasalo; Betty M Tyler; David L Huso; Mahlon D Johnson; Kevin A Walter
Journal:  BMC Cancer       Date:  2009-11-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.